BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32358998)

  • 21. Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension.
    Sartoris R; Rautou PE; Elkrief L; Pollorsi G; Durand F; Valla D; Spahr L; Terraz S; Soubrane O; Cauchy F; Vilgrain V; Ronot M
    Radiology; 2018 Dec; 289(3):698-707. PubMed ID: 30179109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.
    Schwabl P; Bota S; Salzl P; Mandorfer M; Payer BA; Ferlitsch A; Stift J; Wrba F; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2015 Feb; 35(2):381-90. PubMed ID: 24953516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient].
    Jiang FR; Yan HD
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis.
    Liu S; Ma J; Chen P; Liu S; Guo Y; Tan M; Guo X; Feng Y; Wang Q; Li W; Yang C; Gao B; Hua Y; Liu N; Song H; He R; Wang R; Gao Q; Liu C; Qi X
    J Med Virol; 2024 Jan; 96(1):e29380. PubMed ID: 38235849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic venous pressure gradient evaluates the Scheuer stage of liver fibrosis by transjugular liver biopsy: a multicenter study.
    Zhang H; Wang Z; Wei X; Wu H; Li L; Guo W; Li L; Wang R; Yang C; Yan X; Wang F; Yan J; Li X
    HPB (Oxford); 2023 Jun; 25(6):644-649. PubMed ID: 36878751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease.
    Odriozola A; Puente Á; Cuadrado A; Iruzubieta P; Arias-Loste MT; Redondo C; Rivas C; Fábrega E; Crespo J; Fortea JI
    Liver Int; 2023 Jul; 43(7):1446-1457. PubMed ID: 36912787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver Stiffness Assessed by Ultrasound Shear Wave Elastography from General Electric Accurately Predicts Clinically Significant Portal Hypertension in Patients with Advanced Chronic Liver Disease.
    Stefanescu H; Rusu C; Lupsor-Platon M; Nicoara Farcau O; Fischer P; Grigoras C; Horhat A; Stancu O; Ardelean A; Tantau M; Badea R; Procopet B
    Ultraschall Med; 2020 Oct; 41(5):526-533. PubMed ID: 31476787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.
    Lens S; Baiges A; Alvarado-Tapias E; LLop E; Martinez J; Fortea JI; Ibáñez-Samaniego L; Mariño Z; Rodríguez-Tajes S; Gallego A; Bañares R; Puente Á; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; García-Pagán JC; Forns X
    J Hepatol; 2020 Dec; 73(6):1415-1424. PubMed ID: 32535060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation and Validation of a Model to Predict Clinically Significant Portal Hypertension Using Transient Elastography and FIB-4.
    Banini BA; Patel S; Yu JW; Kang L; Bailey C; Strife BJ; Siddiqui MS; Patel V; Matherly SC; Lee H; Lewis S; Cherian R; Stravitz RT; Luketic V; Sanyal AJ; Sterling RK
    J Clin Gastroenterol; 2023 Feb; 57(2):189-197. PubMed ID: 34999644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis.
    Rodrigues SG; Montani M; Guixé-Muntet S; De Gottardi A; Berzigotti A; Bosch J
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2101-2109.e1. PubMed ID: 30625404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India.
    Kumar A; Khan NM; Anikhindi SA; Sharma P; Bansal N; Singla V; Arora A
    World J Gastroenterol; 2017 Jan; 23(4):687-696. PubMed ID: 28216976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.
    Allaire M; Campion B; Demory A; Larrey E; Wagner M; Rudler M; Roux C; Blaise L; Carrie NG; Thabut D
    Aliment Pharmacol Ther; 2023 Aug; 58(3):346-356. PubMed ID: 37300315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications.
    Kitson MT; Roberts SK; Colman JC; Paul E; Button P; Kemp W
    Scand J Gastroenterol; 2015 Apr; 50(4):462-9. PubMed ID: 25623641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of measuring hepatic venous pressure gradient on transjugular liver biopsy for patients with pre-cirrhotic bridging fibrosis liver disease.
    Vu T; Eberly H; Zheng A; Hintze A; McGillen KL; Cruz J; Shin B
    Clin Imaging; 2023 Apr; 96():44-48. PubMed ID: 36801536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.
    Lens S; Alvarado-Tapias E; Mariño Z; Londoño MC; LLop E; Martinez J; Fortea JI; Ibañez L; Ariza X; Baiges A; Gallego A; Bañares R; Puente A; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; Forns X; García-Pagán JC
    Gastroenterology; 2017 Nov; 153(5):1273-1283.e1. PubMed ID: 28734831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splenic T
    Hectors SJ; Bane O; Stocker D; Carbonell G; Lewis S; Kennedy P; Schiano TD; Thung S; Fischman A; Taouli B
    J Magn Reson Imaging; 2020 Sep; 52(3):787-794. PubMed ID: 32073207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.
    Villanueva C; Albillos A; Genescà J; Abraldes JG; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Garcia-Pagan JC; Pavel O; Bosch J
    Hepatology; 2016 Jan; 63(1):197-206. PubMed ID: 26422126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study.
    Levick C; Phillips-Hughes J; Collier J; Banerjee R; Cobbold JF; Wang LM; Piechnik SK; Robson MD; Neubauer S; Barnes E; Pavlides M
    PLoS One; 2019; 14(8):e0221066. PubMed ID: 31430314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
    J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis.
    Noureddin M; Goodman Z; Tai D; Chng ELK; Ren Y; Boudes P; Shlevin H; Garcia-Tsao G; Harrison SA; Chalasani NP
    Aliment Pharmacol Ther; 2023 Feb; 57(4):409-417. PubMed ID: 36647687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.